XJPX
2216
Market cap273mUSD
Oct 09, Last price
1,037.00JPY
1D
1.27%
1Q
-10.60%
Jan 2017
-64.67%
Name
Kanro Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kanro Inc., a Japanese firm headquartered in Tokyo and established in 1950, specializes in the manufacturing and sale of a diverse range of confectionery and food products. Its extensive portfolio includes items such as throat lozenges, various types of candies, chewy gummies, soft marshmallows, and innovative, ingredient-driven snacks. These goods are marketed under numerous prominent brand names, among them Kanro Candy, Puré Gummy, Candemina Gumi, Gold Milk, Play! Gummy, Marosh, and specialized lines like healthy throat lozenges and herbal good products, in addition to many other proprietary labels.
Key people
Tetsuya Murata
President, Chief Executive Officer, Chief Compliance Officer, Representative Director · since 2023
Naoki Sekiguchi
Senior Managing Executive Officer, Chief Director of Research & Technology · since 2026
Mitsuki Sato
Managing Executive Officer, Chief Financial Officer, Chief Information Officer, Chief Director of Accounting and Finance, Chief Director of Digital Solutions, Director · since 2026
Taeko Uchiyama
Managing Executive Officer, Chief Director of Marketing · since 2024
Masahiro Morita
Executive Officer, Chief Director of Production, Chief Director of SCM · since 2024
Hiroko Nishigaya
Executive Officer, Chief Director of Human Resource and General Affairs · since 2024
Shinji Watanabe
Executive Officer, Chief Director of Business Planning · since 2025
Kazuhiro Ishikawa
Senior Managing Executive Officer, Chief Director of Core Business, Director · since 2026
Toyoshige Mizuta
Director · since 2024
Tomohisa Ota
Independent Director · since 2024
Independent Director · since 2026
Yoshikazu Ito
Non-Executive Independent Director · since 2023
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||